Sodium glucose co-transporter 2 inhibitors in heart failure with preserved ejection fraction: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Sodium glucose co-transporter 2 inhibitors in heart failure with preserved ejection fraction: a systematic review and meta-analysis

Published:2021-12-01 Issue: Volume: Page:
ISSN:2047-4873
Container-title:European Journal of Preventive Cardiology
language:en
Short-container-title:

Author:

Tsampasian Vasiliki¹²,Elghazaly Hussein³,Chattopadhyay Rahul²⁴,Ali Omar²,Corballis Natasha¹²,Chousou Panagiota Anna²⁴^ORCID,Clark Allan²,Garg Pankaj¹²,Vassiliou Vassilios S¹²^ORCID

Affiliation:

1. Department of Cardiology, Norfolk and Norwich University Hospitals, Colney Lane, NR4 7UY, Norwich, UK

2. Norwich Medical School, University of East Anglia, Norwich NR4 7TJ, UK

3. Imperial College London and Imperial College NHS Trust, South Kensington, SW7 2BX, London, UK

4. Department of Cardiology, Cambridge University Hospitals, Cambridge CB2 0QQ, UK

Funder

NIHR Academic Clinical Fellowships

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine,Epidemiology

Link

https://academic.oup.com/eurjpc/advance-article-pdf/doi/10.1093/eurjpc/zwab189/41401325/zwab189.pdf

Reference10 articles.

1. Evaluation and management of heart failure with preserved ejection fraction;Borlaug;Nat Rev Cardiol,2020

2. Diastolic ventricular interaction in heart failure with preserved ejection fraction;Parasuraman;J Am Heart Assoc,2019

3. Empagliflozin in heart failure with a preserved ejection fraction;Anker;N Engl J Med,2021

4. Efficacy of ertugliflozin on heart failure-related events in patients with type 2 diabetes mellitus and established atherosclerotic cardiovascular disease: results of the VERTIS CV trial;Cosentino;Circulation,2020

5. Effect of dapagliflozin on heart failure and mortality in type 2 diabetes mellitus;Kato;Circulation,2019

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heart failure with preserved ejection fraction: The role of inflammation;European Journal of Pharmacology;2024-10

2. Effects of different sodium–glucose cotransporter 2 inhibitors in heart failure with reduced or preserved ejection fraction: a network meta-analysis;Frontiers in Cardiovascular Medicine;2024-05-23

3. SGLT2 Inhibition in Heart Failure: Clues to Cardiac Effects?;Cardiology in Review;2024-01-08

4. Heterogeneity in cardiorenal protection by Sodium glucose cotransporter 2 inhibitors in heart failure across the ejection fraction strata: Systematic review and meta-analysis;World Journal of Nephrology;2023-12-25

5. Comparative cardiovascular benefits of individual SGLT2 inhibitors in type 2 diabetes and heart failure: a systematic review and network meta-analysis of randomized controlled trials;Frontiers in Endocrinology;2023-12-20